ArticleArchives of rheumatology2020

Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial.

Toong-Hua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.